{"id":59814,"date":"2024-08-06T22:04:40","date_gmt":"2024-08-06T20:04:40","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/"},"modified":"2024-08-06T22:04:40","modified_gmt":"2024-08-06T20:04:40","slug":"mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/","title":{"rendered":"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference"},"content":{"rendered":"<div>\n<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;<a href=\"https:\/\/twitter.com\/search?q=%24MNMD&amp;src=ctag\" target=\"_blank\" rel=\"noopener\">$MNMD<\/a>&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company\u2019s management team will present at Canaccord Genuity\u2019s 44<sup>th<\/sup> Annual Growth Conference:<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/5\/MNMD_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/5\/MNMD_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/21\/MNMD_Logo.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Canaccord Genuity\u2019s 44th Annual Growth Conference<\/b><\/p>\n<ul class=\"bwlistcircle\">\n<li>\nFormat: Fireside Chat<\/li>\n<li>\nDate and Time: Tuesday, August 13, 2024 at 1:30 PM ET<\/li>\n<li>\nLocation: Boston, MA<\/li>\n<li>\nWebcast Link: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwsw.com%2Fwebcast%2Fcanaccord98%2Fregister.aspx%3Fconf%3Dcanaccord98%26page%3Dmnmd%26url%3Dhttps%3A%2F%2Fwsw.com%2Fwebcast%2Fcanaccord98%2Fmnmd%2F2458676&amp;esheet=54104806&amp;newsitemid=20240806945771&amp;lan=en-US&amp;anchor=Canaccord+Genuity%26%238217%3Bs+44th+Annual+Growth+Conference&amp;index=1&amp;md5=51b59c159ed0ba53831bac44ea3455c2\" rel=\"nofollow noopener\" shape=\"rect\">Canaccord Genuity\u2019s 44th Annual Growth Conference<\/a><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\nAudio webcasts and replays of available presentations will be accessible on MindMed\u2019s <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fir.mindmed.co%2F&amp;esheet=54104806&amp;newsitemid=20240806945771&amp;lan=en-US&amp;anchor=Investor+Relations&amp;index=2&amp;md5=1a3cf489b25fb46f48f86ebdf60d8b20\" rel=\"nofollow noopener\" shape=\"rect\">Investor Relations<\/a> website for up to 90 days following the event.<\/p>\n<p>\n<b>About MindMed<\/b><\/p>\n<p>\nMindMed is a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways that play key roles in brain health disorders. MindMed trades on NASDAQ under the symbol MNMD.<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>For Media:<\/b> <a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;:&#109;&#x65;&#x64;&#105;&#x61;&#x40;m&#105;&#x6e;d&#109;&#x65;&#x64;&#46;&#x63;&#x6f;\" rel=\"nofollow noopener\" shape=\"rect\">m&#101;&#100;&#105;&#x61;&#x40;&#x6d;in&#100;&#109;&#x65;&#x64;&#x2e;&#x63;o<\/a><br \/><b>For Investors:<\/b> <a target=\"_blank\" href=\"&#x6d;&#97;&#105;&#x6c;&#x74;&#111;&#58;&#x69;&#x72;&#64;&#109;&#x69;&#x6e;&#100;&#109;&#x65;&#x64;&#46;&#99;&#x6f;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#114;&#x40;&#x6d;&#105;&#x6e;&#x64;&#109;&#x65;&#x64;&#46;&#x63;&#x6f;<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW YORK&#8211;(BUSINESS WIRE)&#8211;$MNMD&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company\u2019s management team will present at Canaccord Genuity\u2019s 44th Annual Growth Conference: Canaccord Genuity\u2019s 44th Annual Growth Conference Format: Fireside Chat Date and Time: &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-59814","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"NEW YORK&#8211;(BUSINESS WIRE)&#8211;$MNMD&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company\u2019s management team will present at Canaccord Genuity\u2019s 44th Annual Growth Conference: Canaccord Genuity\u2019s 44th Annual Growth Conference Format: Fireside Chat Date and Time: ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-06T20:04:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference\",\"datePublished\":\"2024-08-06T20:04:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/\"},\"wordCount\":197,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240806945771\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/\",\"name\":\"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240806945771\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\",\"datePublished\":\"2024-08-06T20:04:40+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240806945771\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20240806945771\\\/en\\\/2047733\\\/22\\\/MNMD_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/","og_locale":"en_US","og_type":"article","og_title":"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference - Pharma Trend","og_description":"NEW YORK&#8211;(BUSINESS WIRE)&#8211;$MNMD&#8211;Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the \u201cCompany\u201d or \u201cMindMed\u201d), a clinical-stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company\u2019s management team will present at Canaccord Genuity\u2019s 44th Annual Growth Conference: Canaccord Genuity\u2019s 44th Annual Growth Conference Format: Fireside Chat Date and Time: ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/","og_site_name":"Pharma Trend","article_published_time":"2024-08-06T20:04:40+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference","datePublished":"2024-08-06T20:04:40+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/"},"wordCount":197,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/","url":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/","name":"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg","datePublished":"2024-08-06T20:04:40+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20240806945771\/en\/2047733\/22\/MNMD_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/mindmed-to-present-at-canaccord-genuitys-44th-annual-growth-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MindMed to Present at Canaccord Genuity\u2019s 44th Annual Growth Conference"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=59814"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/59814\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=59814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=59814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=59814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}